BMT CTN Protocol 0201
A Phase III Randomized Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors
Below are protocol-related doucments, which may be periodically updated.
- Protocol synopsis, version 8.0 dated September 15, 2006
- Protocol, version 8.0 dated September 15, 2006
- Protocol amendment (summary of changes from version 7.0 to 8.0)
- Informed consents, version 8.0 dated September 15, 2006
- Health Quality of Life (HQL)
- Participating centers
- Educational Materials
- This study is posted on clinicaltrials.gov as NCT00075816
- Key Personnel
Protocol Chair: Claudio Anasetti, MD (813-745-3243) claudio.anasetti@moffitt.org
Protocol Officer: Dennis Confer, MD (612-362-3425) dconfer@nmdp.org
Protocol Coordinator: Kristin Knust (301-251-1161) kknust@emmes.com
Medical Monitor: Chris Bredeson, MD cbredeson@ohri.ca
The BMT CTN #0201 study met its target accrual of 550 patients and closed enrollment on September 9, 2009.
